What Is Zegalogue's Delivery Device?
Zegalogue (dasiglucagon) comes as a ready-to-use auto-injector, not a pre-filled syringe. Each single-dose device delivers 0.6 mg/0.6 mL and requires no preparation—just remove the cap and press against the skin.[1]
How Does It Work for Hypoglycemia Treatment?
Press the auto-injector firmly against the thigh for 2-3 seconds; it injects automatically with a click. It's designed for severe hypoglycemia in adults and kids 6+ years old when IV glucose isn't practical. No needle handling or reconstitution needed, unlike some glucagon kits.[1][2]
Zegalogue vs. Other Glucagon Options
| Product | Device Type | Dose | Key Notes |
|---------|-------------|------|-----------|
| Zegalogue | Auto-injector | 0.6 mg | Ready-to-use; shelf-stable up to 12 months unrefrigerated |
| Glucagon (Eli Lilly) | Prefilled syringe + vial | 1 mg | Requires mixing |
| Baqsimi | Nasal spray | 3 mg | No injection |
| Gvoke | Prefilled syringe | 0.5/1 mg | Syringe, not auto-injector |
Zegalogue stands out for its simplicity in emergencies.[1][3]
Who Makes Zegalogue and Availability?
Zealand Pharma developed it; Novo Nordisk markets it in the US since late 2022. Prescription-only; costs ~$300-400 per dose without insurance.[2][4]
Any Patent or Exclusivity Details?
US patent protection runs through at least 2037 for the formulation and device. Check DrugPatentWatch.com for litigation updates or generics.[5]
Sources:
[1] Zegalogue US Prescribing Information
[2] FDA Label
[3] GoodRx Glucagon Comparison
[4] Novo Nordisk Product Page
[5] DrugPatentWatch.com - Zegalogue